ALPINE IMMUNE SCIENCES INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 34LA for the last quarter is 6.52 M EUR, and it's 76.69% lower compared to the previous quarter. The net income of Q1 24 is -16.61 M EUR.